- Home
- FICO vs MIST Comparison
FICO vs MIST Comparison
Compare FICO & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FICO
- MIST
- Stock Information
- Founded
- FICO 1956
- MIST 2003
- Country
- FICO United States
- MIST Canada
- Employees
- FICO N/A
- MIST N/A
- Industry
- FICO Business Services
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- FICO Consumer Discretionary
- MIST Health Care
- Exchange
- FICO Nasdaq
- MIST Nasdaq
- Market Cap
- FICO 32.2B
- MIST 145.3M
- IPO Year
- FICO 1987
- MIST N/A
- Fundamental
- Price
- FICO $1,552.59
- MIST $1.94
- Analyst Decision
- FICO Buy
- MIST Strong Buy
- Analyst Count
- FICO 12
- MIST 3
- Target Price
- FICO $2,068.67
- MIST $6.33
- AVG Volume (30 Days)
- FICO 308.9K
- MIST 1.2M
- Earning Date
- FICO 11-05-2025
- MIST 11-11-2025
- Dividend Yield
- FICO N/A
- MIST N/A
- EPS Growth
- FICO 34.32
- MIST N/A
- EPS
- FICO 25.55
- MIST N/A
- Revenue
- FICO $1,928,927,000.00
- MIST N/A
- Revenue This Year
- FICO $18.02
- MIST N/A
- Revenue Next Year
- FICO $13.91
- MIST N/A
- P/E Ratio
- FICO $60.72
- MIST N/A
- Revenue Growth
- FICO 16.66
- MIST N/A
- 52 Week Low
- FICO $1,300.00
- MIST $0.63
- 52 Week High
- FICO $2,402.52
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- FICO 58.97
- MIST 64.09
- Support Level
- FICO $1,511.04
- MIST $1.75
- Resistance Level
- FICO $1,598.00
- MIST $2.06
- Average True Range (ATR)
- FICO 42.51
- MIST 0.09
- MACD
- FICO 8.95
- MIST 0.02
- Stochastic Oscillator
- FICO 73.07
- MIST 66.67
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).